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Background
Statins are derived from fungi metabolites and are able to
inhibit HMG-CoA reductase in the mevalonate pathway.
Based on this feature, statins are safely and successfully
used in the treatment of cardiovascular diseases corre-
lated with hypercholesterolemia. Additionally, several
studies have shown that statins have also pleiotropic
effects, like anti-inflammatory, anti-thrombogenic, and
anti-proliferative actions. Previously, we were able to
show that statins have the potential to directly inhibit the
ATP-binding cassette transporter B1 (ABCB1) which
plays a key role in the chemoresistance of several tumor
types [1].
Methods
In add-back assays the simvastatin-induced caspase 3 acti-
vation was measured using fluorescent caspase 3 substrate.
Similarly, glycosylation of ABCB1 was determined by
Western blot analysis. The endogenous dolichol levels
were quantified by thin layer chromatography (TLC) and
high performance liquid chromatography (HPLC) in SH-
SY5Y cells.
Results
Simvastatin reduced the amount of the mature-glycosy-
lated form (180 kDa) while increasing the core-glycosylated
form (140 kDa) of ABCB1. However, this effect and the
apoptosis induction by simvastatin were reversible by addi-
tion of dolichol in a time- and concentration-dependent
manner. Furthermore, our HPLC analyses proved that
endogenous dolichol levels were significantly decreased by
simvastatin treatment for 48 hours. Effects of simvastatin
concentrations as low as 0.1 µM were significant. Finally,
activation of caspase 3 triggered by simvastatin was pre-
vented by addition of dolichol.
Conclusions
Here we show that simvastatin is able to reduce dolichol
levels in SH-SY5Y cells. The endogenous dolichol deple-
tion caused by simvastatin might influence glycosylation
process in the ER leading to alterations of glycosylation
pattern of ABCB1. Moreover, our data suggest that this
correlation between simvastatin and decreased endogen-
ous dolichol levels also correlates with the apoptotic
potential of simvastatin.
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